共 171 条
[31]
Senn S(2013)Tiotropium Respimat inhaler and the risk of death in COPD N Engl J Med 369 1491-62
[32]
Wu AC(2014)Early intervention with tiotropium in Chinese patients with GOLD stages I-II chronic obstructive pulmonary disease (Tie-COPD): study protocol for a multicentre, double-blinded, randomised, controlled trial BMJ Open 4 e003991-9
[33]
Butler MG(2008)Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study Respir Med 102 1511-8
[34]
Li L(2011)Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease Respir Res 12 55-33
[35]
Sadatsafavi M(2012)Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study Eur Respir J 40 830-14
[36]
FitzGerald M(2013)Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD Respir Med 107 1957-68
[37]
Marra C(2010)Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium Am J Respir Crit Care Med 182 155-94
[38]
Lynd L(2011)Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison Eur Respir J 37 273-60
[39]
Holgate ST(2014)Effect of once-daily indacaterol in a predominantly Chinese population with chronic obstructive pulmonary disease: a 26-week Asia-Pacific study Respirology (Carlton, Vic) 19 231-26
[40]
Price D(2013)Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study Lancet Respir Med 1 524-46